Psyence Biomedical Ltd.’s Return on Equity at a glance
Psyence Biomedical Ltd. reports return on equity of 0% for Mar 2025. The prior period recorded 466.2% (Mar 2024). Year over year the metric moved −466.2 pts (−100%). The rolling three-period average stands at 156.5%. Data last refreshed Nov 20, 2025, 7:09 PM.
Latest reading
0% · Mar 2025
YoY movement
−466.2 pts (−100%)
Rolling average
156.5%
Current Return on Equity
0%
−466.2 pts
−100%
Rolling average
156.5%
Latest Value
0%
Mar 2025
YoY Change
−466.2 pts
Absolute
YoY Change %
−100%
Rate of change
3-Period Avg
156.5%
Smoothed
Narrative signal
Psyence Biomedical Ltd.’s return on equity stands at 0% for Mar 2025. Year-over-year, the metric shifted by −466.2 pts, translating into a −100% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
How return on equity shapes Psyence Biomedical Ltd.'s story
As of Mar 2025, Psyence Biomedical Ltd. reports return on equity of 0%. Monitor ROE trends to assess management efficiency and the impact of leverage on profitability.
ROE as a performance score
High and stable ROE signals strong business models and effective capital deployment.
Leverage considerations
Rising debt can boost ROE. Pair the metric with leverage ratios to avoid overstating performance.
Valuation Multiples
Compare how the market prices revenue, equity, and operating cash flow versus peers and history.
Profitability & Margins
Understand cost structure and capital efficiency trends across gross, operating, and net results.
Growth Momentum
Track whether top-line, earnings, and free cash flow growth are accelerating or cooling.
Balance Sheet Strength
Evaluate leverage, liquidity, and cash generation capacity that underpin resilience.
Shareholder Returns
Follow dividend sustainability and cash generation relative to market value.
Psyence Biomedical Ltd. (PBM) FAQs
Answers tailored to Psyence Biomedical Ltd.’s return on equity profile using the latest Financial Modeling Prep data.
What is Psyence Biomedical Ltd.'s current return on equity?
As of Mar 2025, Psyence Biomedical Ltd. reports return on equity of 0%. This reading reflects the latest filings and price data for PBM.
How is Psyence Biomedical Ltd.'s return on equity trending year over year?
Year-over-year, the figure shifts by −466.2 pts (−100%). Pair this context with revenue growth and free cash flow signals to gauge momentum for PBM.
Why does return on equity matter for Psyence Biomedical Ltd.?
Return on equity measures how effectively a company converts shareholder capital into net income. For Psyence Biomedical Ltd., operating within Healthcare — Biotechnology, tracking this metric helps benchmark management's execution against close competitors.
Is Psyence Biomedical Ltd.'s return on equity above its recent average?
Psyence Biomedical Ltd.'s rolling three-period average sits at 156.5%. Comparing the latest reading of 0% to that baseline highlights whether momentum is building or fading for PBM.
How frequently is Psyence Biomedical Ltd.'s return on equity refreshed?
Data for PBM was last refreshed on Nov 20, 2025, 7:09 PM and updates automatically every 24 hours, keeping your valuation inputs current.